pharMAX fibro
Natural health product licensed in Canada
- Licence holder
- Delivra Inc.
- NPN or DIN-HM
- 80031544
- Status
- Active licence
- Licence date
- 18 April 2012
- Revision date
- 19 June 2014
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Olivate de sorbitan, Cetearyl olivate, Butylène glycol, Glycérine, Eau purifiée, Palmitate de cétyle, D-Ribose, Gomme de xanthane, Lauryl carbamate d'inuline, Cera Alba, Chlorphenesin, Palmitate d'isopropyle, Sorbitan Palmitate, Extrait de péricarpe de punica granatum, Lécithine, Rutine, Dromiceius, Creatinine, créatine, Huile de graine de cassis, Ethoxydiglycol, Extrait de fleur de Sambucus nigra, Citrate de potassium, Leptospermum Scoparium Branch/Leaf Oil, Caprylyl Glycol, Extrait de feuille de Peucedanum Ostruthium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 mL ; maximum: 3 mL | 4 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used for the temporary relief of muscle and joint pain associated with rheumatoid arthritis or osteoarthritis, and pain of tendons and ligaments. Used to relieve cutaneous pain associated with conditions such as post-herpetic neuralgia and diabetic neuropathy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80031544
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed. Photograph the packaging